A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT03875482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Risankizumab Using a New Formulation for the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study was to evaluate the safety and efficacy of risankizumab (150 mg/mL) administered by prefilled syringe (PFS) for the treatment of adult participants with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT03875482
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 13, 2019 (Actual)
- Primary completion
- Feb 20, 2020 (Actual)
- Completion
- Jul 15, 2020 (Actual)
- Last update posted
- Mar 16, 2021
2019 – 2020
United States locations
- U.S. sites
- 40
- U.S. states
- 19
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Derm Ctr /ID# 210366 | Birmingham | Alabama | 35205 | — |
| Alliance Dermatology and MOHs /ID# 210645 | Phoenix | Arizona | 85032 | — |
| Hull Dermatology, PA /ID# 210305 | Rogers | Arkansas | 72758 | — |
| Anaheim Clinical Trials LLC /ID# 212559 | Anaheim | California | 92801-2658 | — |
| Wallace Medical Group, Inc. /ID# 210403 | Beverly Hills | California | 90211 | — |
| Dermatology Res. Assoc., CA /ID# 210402 | Los Angeles | California | 90045 | — |
| Integrative Skin Science and Research /ID# 212551 | Sacramento | California | 95815-4500 | — |
| Mosaic Dermatology /ID# 210780 | Santa Monica | California | 90404 | — |
| Skin Care Research, LLC /ID# 210514 | Boca Raton | Florida | 33486-2269 | — |
| ACCEL Research Sites /ID# 212709 | DeLand | Florida | 32720 | — |
| Multi-Speciality Research Associates /ID# 211625 | Lake City | Florida | 32055-8835 | — |
| GSI Clinical Research, LLC /ID# 210330 | Margate | Florida | 33063 | — |
| Suncoast Clinical Research /ID# 210874 | New Port Richey | Florida | 34652 | — |
| Ormond Medical Arts Pharmaceutical Research Center /ID# 212781 | Ormond Beach | Florida | 32174-6302 | — |
| Progressive Medical Research /ID# 210877 | Port Orange | Florida | 32127 | — |
| Precision Clinical Research /ID# 212921 | Sunrise | Florida | 33351-7311 | — |
| Lenus Research & Medical Group /ID# 212584 | Sweetwater | Florida | 33172 | — |
| Treasure Valley Dermatology /ID# 212707 | Boise | Idaho | 83713-0997 | — |
| Sneeze, Wheeze, & Itch Associates, LLC /ID# 212562 | Normal | Illinois | 61761 | — |
| The Indiana Clinical Trials Center /ID# 210205 | Plainfield | Indiana | 46168 | — |
| Forefront Dermatology /ID# 210520 | Louisville | Kentucky | 40202-2862 | — |
| DS Research /ID# 210272 | Louisville | Kentucky | 40241-6162 | — |
| David Fivenson, MD, PLC /ID# 210193 | Ann Arbor | Michigan | 48103 | — |
| Clarkston Skin Research /ID# 210197 | Clarkston | Michigan | 48346 | — |
| Henry Ford Medical Center /ID# 211598 | Detroit | Michigan | 48202-3046 | — |
| Cleaver Dermatology /ID# 210300 | Kirksville | Missouri | 63501-5362 | — |
| Advanced Dermatology of the Midlands /ID# 212763 | Omaha | Nebraska | 68144-1105 | — |
| Skin Specialists, PC /ID# 211490 | Omaha | Nebraska | 68144 | — |
| Psoriasis Treatment Ctr NJ /ID# 210837 | East Windsor | New Jersey | 08520 | — |
| Skin Laser and Surgery Specialists of NY and NJ /ID# 210208 | Hackensack | New Jersey | 07601-1997 | — |
| DermResearchCenter of NY, Inc. /ID# 210652 | Stony Brook | New York | 11790 | — |
| WDC Cosmetic and Research, PLLC /ID# 210372 | Wilmington | North Carolina | 28403 | — |
| Lynn Health Science Institute (LHSI) /ID# 213216 | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Partners, LLC /ID# 210642 | Johnston | Rhode Island | 02919 | — |
| Palmetto Clinical Trial Services /ID# 210368 | Fountain Inn | South Carolina | 29644-1928 | — |
| Coastal Carolina Research Ctr /ID# 213069 | Mt. Pleasant | South Carolina | 29464 | — |
| Arlington Research Center, Inc /ID# 210344 | Arlington | Texas | 76011 | — |
| Center for Clinical Studies - Houston (Binz) /ID# 210361 | Houston | Texas | 77004-8097 | — |
| Progressive Clinical Research /ID# 210359 | San Antonio | Texas | 78229 | — |
| Acclaim Dermatology /ID# 212252 | Sugar Land | Texas | 77479-2645 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03875482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03875482 live on ClinicalTrials.gov.